Alpha-GPC
Also sold as: Choline Alfoscerate, Cerepro, Cereton, Gliatilin
Best-in-class: Alpha-GPC
The most bioavailable choline source, rapidly raising acetylcholine for focus, memory and — for athletes — power output and growth-hormone response.
Alpha-GPC quick facts
| Suggested dose | 300–600 mg, often pre-workout or in the morning. |
| How often | Daily on training or working days |
| Who it's for | Focus, memory and power/performance — a top nootropic-plus-performance pick. |
The default choline source, and effectively mandatory alongside any racetam — the headaches people get on piracetam or pramiracetam are usually acetylcholine depletion and resolve with this. Human trials also show improved power output, which is a separate and often-missed use. One observational signal has linked high intake to stroke risk via TMAO, which is unresolved and worth watching rather than panicking over.
How Alpha-GPC actually works
L-alpha-glycerylphosphorylcholine is the most bioavailable choline donor that crosses the blood-brain barrier intact, where it is cleaved to supply choline for acetylcholine synthesis and glycerophosphate for membrane phospholipid. Acetylcholine is the neurotransmitter of attention and memory encoding, and it is the one racetams deplete by increasing turnover without increasing supply. It also triggers an acute growth hormone release through an incompletely characterized route.
Where to get Alpha-GPC
Find Alpha-GPC on iHerb →The evidence for Alpha-GPC
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show improved power output and a growth-hormone bump when taken pre-exercise.
- Supports memory/attention and cognitive function, studied even in cognitive decline.
📊 Correlative data
- Choline availability supports acetylcholine-dependent cognition and muscle contraction.
🧪 Theoretical / extrapolated benefits
- Broad nootropic 'mind-muscle' benefits are well-grounded in the cholinergic mechanism.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Alpha-GPC actually does
Alpha-GPC is L-alpha-glycerylphosphorylcholine, molecular weight 257, carrying one choline head group of 104. That is about 41% choline by mass, which is the highest fraction of any common choline product and the entire pharmacological argument for it. Citicoline, the molecule most buyers are choosing between, is about 21%.
It is not a synthetic precursor. It is a breakdown intermediate. Alpha-GPC is what a cell produces when it deacylates phosphatidylcholine — membrane taken apart, two fatty acids removed, the glycerophosphocholine backbone left over. Swallowing it means putting a membrane catabolite back in at the top of the pathway that rebuilds membrane, and glycerophosphodiester phosphodiesterase splits it to free choline and glycerol-3-phosphate before it does anything else. From there the choline runs the Kennedy pathway: choline kinase, then CTP:phosphocholine cytidylyltransferase — the rate-limiting, amphitropic, membrane-sensing enzyme that speeds up only when the membrane is actually short of phosphatidylcholine Cornell 2015 — then cholinephosphotransferase. Alpha-GPC enters that funnel at exactly the same place citicoline does, which is the fact that makes these two products comparable at all.
The cholinergic claim needs one more enzyme, and it is the one nobody names. Choline acetyltransferase makes acetylcholine, but the step that actually paces acetylcholine synthesis in a nerve terminal is the high-affinity choline transporter CHT1, the product of SLC5A7, which pulls choline back out of the synaptic cleft. If that transporter is already working near saturation at normal plasma choline — and plasma choline is homeostatically defended Obeid 2023 — then raising plasma choline further moves the substrate concentration without moving the flux. “More choline, therefore more acetylcholine” is a syllogism with an unstated premise, and no human study has tested it at supplement doses.
The endocrine effect is separate and is real. Glycerophosphocholine raised growth hormone secretion and fat oxidation in young adults Kawamura 2012. That is an acute hormonal response, not a training adaptation, and a growth hormone pulse is something almost anything stressful will produce.
Cell, rodent, human — and where it stops
The enzymology is about membranes Cornell 2015. Everything below is a clinical question, and every clinical answer comes from a population with a diagnosis.
Rodent, and it is a vascular result rather than a cognitive one. In hyperlipidemic Apoe-knockout mice, alpha-GPC promoted atherosclerosis, acting through trimethylamine-N-oxide and an altered gut microbiota Wang 2021. That is the first animal experiment in this entry and its endpoint is plaque.
Human, Alzheimer's disease. A multicenter, double-blind, randomized, placebo-controlled trial of choline alfoscerate in mild to moderate Alzheimer's dementia reported cognitive improvement De Jesus Moreno Moreno 2003. Human, mild cognitive impairment: 100 subjects randomized to 600 mg of alpha-GPC or placebo for 12 weeks, with the Alzheimer's Disease Assessment Scale-cognitive subscale as the primary outcome; ADAS-cog fell by 2.34 points more on alpha-GPC than on placebo, with no serious adverse events and no difference in adverse event rates Jeon 2024.
Human, cerebrovascular. An Italian multicenter trial used alpha-glycerophosphocholine in the mental recovery phase after cerebral ischemic attacks Barbagallo Sangiorgi 1994, and the meta-analytic literature on choline-containing phospholipids sits in stroke treatment Sagaro 2023 and in adult-onset cognitive dysfunction, largely alongside donepezil Sagaro 2023.
Now the obstacle, and it is a population and a scale obstacle. Every cognitive result above was obtained in people carrying a diagnosis — Alzheimer's disease, mild cognitive impairment, or a completed stroke. ADAS-cog is a 70-point instrument built to detect decline in dementia; a 2.34-point advantage in people who already have measurable impairment Jeon 2024 is a real clinical signal and is not translatable to a 30-year-old who would score at ceiling on the same test on day one. There is no randomized trial of alpha-GPC for focus, attention or memory in cognitively normal adults under 50. The only healthy-adult human data in this entry is an acute growth hormone and fat oxidation measurement Kawamura 2012, and that is not a cognitive endpoint at all.
Alpha-GPC — which form, and does it matter
Work the choline arithmetic and the shelf reorders itself. Alpha-GPC is about 41% choline by mass; choline bitartrate is about 41%; citicoline is about 21%. Six hundred milligrams of alpha-GPC therefore delivers roughly 246 mg of choline, which is more choline than 1,000 mg of citicoline delivers. If choline delivery is what you want, this is the efficient purchase. If you wanted the cytidine that comes with citicoline, it is the wrong one. Neither label frames it as a choice.
The specification that decides what is actually in the capsule. Alpha-GPC is strongly hygroscopic: raw material pulls water out of the air and cakes, so it is commonly sold adsorbed onto silica at 50%. A powder declaring “Alpha-GPC 600 mg” may be 600 mg of a 50% preparation, which is 300 mg of alpha-GPC and about 123 mg of choline. This is a label question with a factor-of-two answer, it is checkable on the tub, and it is the single most useful thing to read before buying. Look for “Alpha-GPC (50%)” or a stated yield.
Match the trial material if you are going to run the experiment. The controlled trials used 600 mg per day for 12 weeks in mild cognitive impairment Jeon 2024 and roughly 1,200 mg per day in Alzheimer's dementia De Jesus Moreno Moreno 2003. The card's 300–600 mg puts its lower end at half the smallest dose that has ever been tested against a cognitive endpoint.
And read the counter-ion trap in the other direction. Choline bitartrate delivers the same choline fraction for a fraction of the price and is what a person actually wants if the goal is choline intake rather than the specific glycerophosphocholine molecule. Nobody has ever run alpha-GPC against an equimolar dose of choline bitartrate with a shared endpoint, which means the premium is currently unearned by evidence.
What would have to be true, and how you would know it was not
1. The prediction that cuts against the product, and it has a blood test. Fasting TMAO before starting and again after 6 weeks at 600 mg per day. Predict it rises. Alpha-GPC is 41% choline, gut bacteria convert a share of any choline load to trimethylamine, hepatic flavin-containing monooxygenase 3 oxidizes that to TMAO, and TMAO tracked major adverse cardiovascular events with a hazard ratio of 2.54 across 4,007 patients undergoing coronary angiography Tang 2013. The supplement version of that experiment has already been run in mice and it produced plaque Wang 2021. TMAO is orderable, and this is the one number that would make the cardiovascular question personal rather than statistical.
2. Cognition, on an instrument, at the dose that was tested. A 10-minute psychomotor vigilance task plus a delayed word-list recall at day 0 and day 84, on 600 mg per day, at the same hour, with caffeine held constant. Predict no change if you are under 50 and cognitively normal, because the only positive cognitive results are in diagnosed impairment Jeon 2024 De Jesus Moreno Moreno 2003. Score lapses and recalled words, not how sharp you felt.
3. The performance claim, tested as a performance claim. Peak force on a fixed protocol — same lift, same rest, same time of day — at day 0 and day 42. Predict no meaningful change, and predict specifically that any growth hormone response Kawamura 2012 does not show up as strength, because an acute hormone pulse and a six-week training adaptation are different measurements.
What will fool you: the pre-workout. Alpha-GPC is almost never taken alone; it arrives inside a stack with caffeine, tyrosine and citrulline, and every one of those has an acute effect on exactly what you are trying to score. Take it by itself for the six weeks or you have tested the tub.
What nobody has tested yet
Nobody has drawn a TMAO before and after a course of alpha-GPC in a human. The mouse experiment exists Wang 2021, the human epidemiology of TMAO exists Tang 2013, and the national cohort signal exists Lee 2021. The study that would join them is six weeks, two blood draws and thirty people, and it has not been published. That absence is the reason the safety section below has to hedge.
Nobody has tested alpha-GPC in cognitively normal adults under 50. That is the entire market. A 12-week randomized trial at 600 mg with an objective attention battery would be cheaper than the dementia trials already run De Jesus Moreno Moreno 2003 Jeon 2024 and it does not exist.
Nobody has separated the choline from the glycerophosphate. A three-arm trial — alpha-GPC, an equimolar choline bitartrate dose, and placebo — would establish whether this molecule is anything more than an efficient choline salt with a premium price. Given that it is cleaved before it reaches a cell, that is not a cynical question.
And nobody has repeated the stroke analysis where alpha-GPC is a supplement. The signal comes from a country where it is a prescription drug given to older people for cognitive complaints Lee 2021. A cohort of healthy supplement users, where the reason for taking it is not a brain symptom, would separate the drug from the indication in a way no amount of covariate matching can.
Alpha-GPC — its own safety story, not its category's
The cardiovascular observation, stated exactly. A population-based retrospective cohort study used the National Health Insurance Service database of South Korea and included 12,008,977 men and women aged 50 or older with no prior stroke and no Alzheimer's disease. Participants were classified by whether they were prescribed alpha-GPC during 2006–2008 and followed for incident stroke from 1 January 2009 to 31 January 2018. Compared with 11,900,100 nonusers, the 108,877 users had a higher risk of total stroke, with an adjusted hazard ratio of 1.46 (95% CI 1.43–1.48), ischemic stroke 1.36 (1.33–1.39) and hemorrhagic stroke 1.36 (1.28–1.44). After matching users to nonusers on all covariates the figures were 1.43 (1.41–1.46), 1.34 (1.31–1.37) and 1.37 (1.29–1.46), and longer prescription duration was associated with higher risk in a dose-response manner Lee 2021.
What that study can establish, and what it cannot. It establishes an association large enough and consistent enough across stroke subtypes, with a duration gradient, that it cannot be dismissed as noise — twelve million people is not a small study. It cannot establish causation, and the specific reason is confounding by indication. In Korea alpha-GPC is a prescription medicine given for cognitive complaints, and before matching the users were on average 6.7 years older than the nonusers — mean age 68.3 versus 61.6 years Lee 2021. People prescribed a cognitive drug are people whose physicians were worried about their brains, and small vessel cerebrovascular disease is the commonest reason for that worry. Matching on recorded covariates cannot balance a symptom nobody coded. A retrospective claims analysis of a drug given for an early sign of the disease it is then found to predict is the textbook setting for this error. This is a reason to run the trial, not a verdict.
Why it is still worth taking seriously. There is a mechanism, and it is the same one that runs through every choline product on this site: choline is the substrate gut bacteria turn into trimethylamine, which the liver oxidizes to TMAO, which tracked cardiovascular events at a hazard ratio of 2.54 in 4,007 patients Tang 2013; and alpha-GPC specifically promoted atherosclerosis in Apoe-knockout mice through TMAO and gut microbiota changes Wang 2021. Alpha-GPC carries roughly twice the choline per milligram that citicoline does, so on this axis it is the larger version of the same load, not a different molecule.
The ordinary side effects. Headache is the commonest complaint and usually means the dose is too high. Nausea, sweating and vivid dreams are the cholinergic pattern, and they mean come down rather than push through. In the mild cognitive impairment trial no participant discontinued for an adverse event and the adverse event rate did not differ from placebo Jeon 2024.
Who should not take it: anyone with a prior stroke or transient ischemic attack, or with atrial fibrillation, until the 2021 cohort signal is resolved Lee 2021; anyone taking a cholinesterase inhibitor such as donepezil, because that is the same axis approached from the other end; anyone already taking citicoline, phosphatidylcholine or a high-choline multivitamin, because these all add on the same TMAO axis Tang 2013; and anyone taking it instead of investigating a genuine change in memory, which is an assessment rather than a purchase.
Sources read for this page
- Lee G, Choi S, et al. Association of L-alpha Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Network Open 2021 · PMID 34817582
- Wang Z, et al. The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis. International Journal of Molecular Sciences 2021 · PMID 34948275
- Tang WH, Wang Z, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine 2013 · PMID 23614584
- Sagaro GG, et al. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease 2023 · PMID 36683513
- Jeon J, et al. Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial. BMC Geriatrics 2024 · PMID 39300341
- De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical Therapeutics 2003 · PMID 12637119
- Kawamura T, et al. Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults. Nutrition 2012 · PMID 22673596
- Barbagallo Sangiorgi G, et al. alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Annals of the New York Academy of Sciences 1994 · PMID 8030842
- Sagaro GG, Amenta F. Choline-Containing Phospholipids in Stroke Treatment: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2023 · PMID 37109211
- Cornell RB, Ridgway ND. CTP:phosphocholine cytidylyltransferase: Function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis. Progress in Lipid Research 2015 · PMID 26165797
- Obeid R, et al. Choline - a scoping review for Nordic Nutrition Recommendations 2023. Food & Nutrition Research 2023 · PMID 38187796
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Two endpoints that have nothing to do with each other. In the gym: peak power on a lift you already track — bar speed, or a top set you can repeat. At the desk: whether you hold one task for a whole block without the tab-switching. Score them apart, because getting one and not the other is the common result.
- How long before it means anything: Same-day, 30 to 60 minutes ahead of the session or the work. Both effects are acute, so if six sessions on it look like six sessions off it, another month will not change the answer.
- What will fool you: Pre-workout stacking. Almost nobody takes alpha-GPC alone before training, and the caffeine, citrulline and creatine in the same scoop are all moving the numbers you are scoring. Isolate it: same warm-up, same lift, same time of day, one variable changed.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Alpha-GPC — safety & side effects
- Headache is the commonest complaint and usually means the dose is too high. Nausea, and a cholinergic low mood in some people at sustained high doses.
- One signal worth knowing: an observational analysis linked higher alpha-GPC intake with increased stroke risk over ten years. It is associational, contested, and not confirmed — but it is real enough to mention rather than omit.
- Cholinergic, so it interacts with anticholinergic medication. Avoid with cholinergic prescriptions unless supervised.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Alpha-GPC in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Alpha-GPC
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Alpha-GPC — frequently asked questions
What is Alpha-GPC?
The most bioavailable choline source, rapidly raising acetylcholine for focus, memory and — for athletes — power output and growth-hormone response.
What is the suggested dose of Alpha-GPC?
300–600 mg, often pre-workout or in the morning. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Alpha-GPC dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Alpha-GPC?
Coach Cam sources Alpha-GPC from vetted, top-rated brands on iHerb — use the buy link on this page.
Alpha-GPC inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Alpha-GPC is used for
Alpha-GPC appears under 1 goal in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Alpha-GPC is the cholinergic arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.